Reading Time: 3 minutes Drugmakers and research centres around the world are working on COVID-19 vaccines, with large global trials of several of the candidates involving tens of thousands of participants well underway. The following is what we know about the race to deliver vaccines to help end the coronavirus pandemic that has claimed more than 1
According to tests on thousands of volunteers, the Oxford vaccine, which is being developed by AstraZeneca is up to 90% effective in preventing COVID-19. The result compared with the Pfizer and Moderna vaccines which were recently shown to be 95% and 94.5% effective respectively. “We have a vaccine for the world,” Professor Andrew Pollard, chief investigator
Reading Time: 2 minutes AstraZeneca’s chief executive officer Pascal Soriot said on Monday that the lower first dose of its experimental COVID-19 vaccine meant more people can be vaccinated more quickly, as the British drugmaker unveiled interim late-stage trial results. “Being able to vaccinate more people faster is a really a big plus,” he told a
A Covid-19 vaccine developed at Oxford University by AstraZeneca is up to 90% effective according to tests carried out on thousands of volunteers. The result compares with the Pfizer and Moderna vaccines, which were recently shown to be 95% and 94.5% effective respectively. The chief investigator of the Oxford Vaccine Trial at Oxford, Professor Andrew
“This vaccine’s efficacy and safety confirm that it will be highly effective against COVID-19 and will have an immediate impact on this public health emergency British drugs group AstraZeneca and the University of Oxford on Monday said their jointly-developed vaccine against COVID-19 has shown “an average efficacy of 70 per cent” in trials. “This vaccine’s
Reading Time: 2 minutes The vaccine developed by the University of Oxford stops 70% of people developing Covid symptoms, a large scale trial shows. It is both a triumph and a disappointment after vaccines by Pfizer and Moderna showed 95% protection. However, the Oxford jab is far cheaper, and is easier to store and get to every corner of the world
A COVID-19 vaccine being developed by Oxford University and AstraZeneca can prevent 70.4% of people from contracting the virus, new data shows. The vaccine was found to be effective in preventing people of all ages, including the elderly, from getting COVID-19. “The announcement today takes us another step closer to the time when we can use vaccines
Pexels The vaccine developed by the University of Oxford stops 70% of people developing Covid symptoms, a large scale trial shows. It is both a triumph and a disappointment after vaccines by Pfizer and Moderna showed 95% protection. However, the Oxford jab is far cheaper, and is easier to store and get to every corner of the world than the other two